Questionable ethics--whistle-blowing or tale-telling?
Renal biopsy is a potentially hazardous procedure, generally performed for therapeutic reasons. An open renal biopsy was performed when there appeared to be no accepted clinical indication and its results published in a specialty journal, whose editors declined publication of subsequent correspondence, questioning the ethical propriety of such a procedure. The implications for clinical practice, authors, editors and readers are discussed.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- ACP Best Practice No 160. Renal biopsy specimens
- Value of repeat biopsy in lupus nephritis flares
- Southern Regional Meeting Abstracts
- Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis
- Handling of renal biopsies: different approaches reflect a lack of evidence for what constitutes “best practice”
- Incidence of major complications after percutaneous native renal biopsies in adults from low-income to middle-income countries: a protocol for systematic review and meta-analysis
- Dataset for the reporting of renal biopsy for tumour: recommendations from the International Collaboration on Cancer Reporting (ICCR)
- Southern Regional Meeting 2017, New Orleans, LA, February 11-13, 2017
- Presentation, pathology and prognosis of renal disease in type 2 diabetes